Chunxia Cronin

693 total citations
17 papers, 523 citations indexed

About

Chunxia Cronin is a scholar working on Physiology, Molecular Biology and Surgery. According to data from OpenAlex, Chunxia Cronin has authored 17 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Chunxia Cronin's work include Adenosine and Purinergic Signaling (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Signaling Pathways in Disease (3 papers). Chunxia Cronin is often cited by papers focused on Adenosine and Purinergic Signaling (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Signaling Pathways in Disease (3 papers). Chunxia Cronin collaborates with scholars based in United States, China and Canada. Chunxia Cronin's co-authors include Bruce T. Liang, Kenneth A. Jacobson, Rajkumar Verma, Jianbing Shen, Saibal Chakraborty, T. Santhosh Kumar, Tiehong Yang, Venugopal Reddy Venna, Li‐Juan Duan and Jacob Hudobenko and has published in prestigious journals such as Circulation, The Journal of Immunology and The FASEB Journal.

In The Last Decade

Chunxia Cronin

16 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chunxia Cronin United States	11	159	143	128	88	61	17	523
Jessie Gu United States	9	379 2.4×	137 1.0×	94 0.7×	41 0.5×	26 0.4×	11	976
Pier Andrea Borea Italy	7	226 1.4×	67 0.5×	281 2.2×	42 0.5×	51 0.8×	8	485
Valeria Iannotta Italy	9	202 1.3×	66 0.5×	295 2.3×	53 0.6×	30 0.5×	9	451
Valentina Vultaggio-Poma Italy	13	288 1.8×	27 0.2×	374 2.9×	82 0.9×	97 1.6×	24	724
Jürgen W. A. Sijbesma Netherlands	16	231 1.5×	35 0.2×	21 0.2×	52 0.6×	47 0.8×	41	586
Cindy van Roomen Netherlands	12	279 1.8×	195 1.4×	39 0.3×	13 0.1×	70 1.1×	14	1.0k
Marta Calbet Spain	14	210 1.3×	56 0.4×	57 0.4×	23 0.3×	53 0.9×	23	461
Ameet A. Chimote United States	15	277 1.7×	19 0.1×	81 0.6×	26 0.3×	168 2.8×	25	519
Liaman K. Mamedova Israel	9	194 1.2×	36 0.3×	231 1.8×	26 0.3×	22 0.4×	12	388
Marcus Grohmann Germany	8	194 1.2×	13 0.1×	137 1.1×	14 0.2×	54 0.9×	12	520

Countries citing papers authored by Chunxia Cronin

Since Specialization

Citations

This map shows the geographic impact of Chunxia Cronin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunxia Cronin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunxia Cronin more than expected).

Fields of papers citing papers by Chunxia Cronin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunxia Cronin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunxia Cronin. The network helps show where Chunxia Cronin may publish in the future.

Co-authorship network of co-authors of Chunxia Cronin

This figure shows the co-authorship network connecting the top 25 collaborators of Chunxia Cronin. A scholar is included among the top collaborators of Chunxia Cronin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunxia Cronin. Chunxia Cronin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Tosh, Dilip K., Matteo Pavan, Chunxia Cronin, et al.. (2024). 2-Substituted (N)-Methanocarba A₃ Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo Characterization. ACS Pharmacology & Translational Science. 7(7). 2154–2173. 4 indexed citations

Cronin, Chunxia, et al.. (2024). Revealing the Novel Role of Purinergic Receptor P2X4 in Phagocytic Uptake After Ischemic Stroke. Journal of the American Heart Association. 13(19). e037148–e037148.

Jung, Kwan‐Young, Zhan‐Guo Gao, John C.R. Randle, et al.. (2023). Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y ₁₄ Receptor Antagonists. Journal of Medicinal Chemistry. 66(13). 9076–9094. 15 indexed citations

Phoenix, Kathryn N., Zhichao Yue, Lixia Yue, et al.. (2022). PLCβ2 Promotes VEGF-Induced Vascular Permeability. Arteriosclerosis Thrombosis and Vascular Biology. 42(10). 1229–1241. 16 indexed citations

Liu, Wei, Chunxia Cronin, Chengliang Wang, et al.. (2022). Nexinhib20 Inhibits Neutrophil Adhesion and β2 Integrin Activation by Antagonizing Rac-1–Guanosine 5′-Triphosphate Interaction. The Journal of Immunology. 209(8). 1574–1585. 10 indexed citations

Liu, Wei, Chunxia Cronin, Chengliang Wang, et al.. (2022). Nexinhib20 prevents myocardial ischemia‐reperfusion injury by inhibiting neutrophil adhesion and β2 integrin activation. The FASEB Journal. 36(S1). 1 indexed citations

Srivastava, Pranay, Chunxia Cronin, Victoria Scranton, et al.. (2020). Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke. Experimental Neurology. 329. 113308–113308. 64 indexed citations

Shen, Jianbing, Kiran S. Toti, Saibal Chakraborty, et al.. (2020). Prevention and rescue of cardiac dysfunction by methanocarba adenosine monophosphonate derivatives. Purinergic Signalling. 16(1). 61–72. 6 indexed citations

Verma, Rajkumar, Chunxia Cronin, Jacob Hudobenko, et al.. (2017). Deletion of the P2X4 receptor is neuroprotective acutely, but induces a depressive phenotype during recovery from ischemic stroke. Brain Behavior and Immunity. 66. 302–312. 73 indexed citations

10.

Pereira, Flavia, Chunxia Cronin, Mallika Ghosh, et al.. (2013). CD13 is essential for inflammatory trafficking and infarct healing following permanent coronary artery occlusion in mice. Cardiovascular Research. 100(1). 74–83. 25 indexed citations

11.

Kumar, T. Santhosh, Tiehong Yang, Chunxia Cronin, et al.. (2013). 5′-Phosphate and 5′-Phosphonate Ester Derivatives of (N)-Methanocarba Adenosine with in Vivo Cardioprotective Activity. Journal of Medicinal Chemistry. 56(3). 902–914. 130 indexed citations

12.

Ho, Vivienne C., Li‐Juan Duan, Chunxia Cronin, Bruce T. Liang, & Guo‐Hua Fong. (2012). Elevated Vascular Endothelial Growth Factor Receptor-2 Abundance Contributes to Increased Angiogenesis in Vascular Endothelial Growth Factor Receptor-1–Deficient Mice. Circulation. 126(6). 741–752. 58 indexed citations

13.

Сонин, Д. Л., Siyuan Zhou, Chunxia Cronin, et al.. (2008). Role of P2X purinergic receptors in the rescue of ischemic heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 295(3). H1191–H1197. 33 indexed citations

14.

Сонин, Д. Л., et al.. (2007). Cardiac‐specific Overexpression of Human P2X4 Purinergic Receptors Confers a Beneficial Effect in Left Anterior Descending Artery Ligation Model of Ischemic Cardiomyopathy. The FASEB Journal. 21(6). 2 indexed citations

15.

Shen, Jianbing, Chunxia Cronin, Д. Л. Сонин, et al.. (2006). P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 292(2). H1077–H1084. 29 indexed citations

16.

Oliver, Bonnie, et al.. (2004). Divergent stress responses to IL‐1β, nitric oxide, and tunicamycin by chondrocytes. Journal of Cellular Physiology. 204(1). 45–50. 55 indexed citations

17.

Oliver, Bonnie, et al.. (2003). Two alanines juxtaposed to aggrecan's G1 domain alter its intracellular localization. Journal of Cellular Biochemistry. 90(3). 592–607. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact